ResearcherFirst Affiliated Hospital of Zhengzhou UniversityNo recent work listed

Dan Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8313-4343; OpenAlex author ID A5022835603. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Risk Assessment of Liver Metastasis in Pancreatic Cancer Patients Using Multiple Models Based on Machine Learning: A Large Population-Based Study. Co-author DOI 10.1155/2022/1586074 ↗
Ro60/SSA levels are increased and promote the progression of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.bbrc.2017.12.124 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jiyuan Xing · 1 shared paper, 2022 · strength 0.19
- Paper Risk Assessment of Liver Metastasis in Pancreatic Cancer Patients Using Multiple Models Based on Machine Learning: A La… DOI 10.1155/2022/1586074 ↗
Xiaobo Hu · 1 shared paper, 2022 · strength 0.19
- Paper Risk Assessment of Liver Metastasis in Pancreatic Cancer Patients Using Multiple Models Based on Machine Learning: A La… DOI 10.1155/2022/1586074 ↗
Qinggang Li · 1 shared paper, 2022 · strength 0.19
- Paper Risk Assessment of Liver Metastasis in Pancreatic Cancer Patients Using Multiple Models Based on Machine Learning: A La… DOI 10.1155/2022/1586074 ↗
Lingjian Kong · 1 shared paper, 2018 · strength 0.12
- Paper Ro60/SSA levels are increased and promote the progression of pancreatic ductal adenocarcinoma. DOI 10.1016/j.bbrc.2017.12.124 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.